EP Biocomposites Ltd (NSE: EPBIO), ISIN INE0D2I01014 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
EPBIO last traded at ₹106.00 (+9.27%), with a 52-week range of ₹75.50 to ₹149.90 (as of 30 Jul 2026).
Shareholding as of Dec 2025: promoters 70.08%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 67/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.